ADC Therapeutics
ADCT
ADCT
41 hedge funds and large institutions have $35.4M invested in ADC Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
60% less call options, than puts
Call options by funds: $2K | Put options by funds: $5K
64% less capital invested
Capital invested by funds: $97.5M → $35.4M (-$62.1M)
78% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 18
Holders
41
Holding in Top 10
2
Calls
$2K
Puts
$5K
Top Buyers
| 1 | +$1.1M | |
| 2 | +$449K | |
| 3 | +$261K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$119K |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$115K |
Top Sellers
| 1 | -$5.93M | |
| 2 | -$2.63M | |
| 3 | -$677K | |
| 4 |
SCM
Sio Capital Management
New York
|
-$651K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$523K |